Evidence map›Paper›PMID 33259517›Full record

ArticlePloS one2020

Proactive prevention: Act now to disrupt the impending non-communicable disease crisis in low-burden populations.

Benson Njuguna, Sara L Fletcher, Constantine Akwanalo, Kwaku Poku Asante, Ana Baumann, Angela Brown, Victor G Davila-Roman, Julia Dickhaus, Meredith Fort, Juliet Iwelunmor and 12 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Benson NjugunaDepartment of Pharmacy, Moi Teaching & Referral Hospital, Eldoret, Kenya.ORCID 0000-0002-6537-3671
Sara L FletcherOregon State University College of Pharmacy, Corvallis, OR, United States of America.ORCID 0000-0002-6683-1603
Constantine AkwanaloDepartment of Cardiology, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Kwaku Poku AsanteKintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana.
Ana BaumannBrown School of Social Work, Washington University in St. Louis, St. Louis, MO, United States of America.
Angela BrownCardiovascular Division, Washington University School of Medicine, St. Louis, MO, United States of America.
Victor G Davila-RomanCardiovascular Division, Washington University School of Medicine, St. Louis, MO, United States of America.
Julia DickhausDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
Meredith FortColorado School of Public Health, Aurora, CO, United States of America.
Juliet IwelunmorDepartment of Behavioral Science and Health Education, College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, United States of America.
Vilma IrazolaDepartment of Research in Chronic Diseases, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Sailesh MohanPublic Health Foundation of India (PHFI), Gurgaon, Haryana, India.
Vincent MutabaziRegional Alliance for Sustainable Development-Rwanda, Kigali, Rwanda.
Brad NewsomeCenter for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States of America.
Olugbenga OgedegbeDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
Sonak D PastakiaPurdue University College of Pharmacy, Center for Health Equity and Innovation, West Lafayette, IN, United States of America.
Emmanuel K PeprahDepartment of Social and Behavioral Sciences, Global Health Program, NYU School of Global Public Health, New York, NY, United States of America.
Jacob Plange-RhuleGhana College of Physicians and Surgeons, Accra, Ghana.
Gregory RothDivision of Cardiology, University of Washington, Seattle, WA, United States of America.
Archana ShresthaDepartment of Public Health, Kathmandu University School of Medical Sciences, Dhulikhel, Kavrepalanchwok, Nepal.
David A WatkinsDepartment of Global Health, University of Washington, Seattle, WA, United States of America.
Rajesh VedanthanDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.ORCID 0000-0001-7138-2382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-communicable disease (NCD) prevention efforts have traditionally targeted high-risk and high-burden populations. We propose an alteration in prevention efforts to also include emphasis and focus on low-risk populations, predominantly younger individuals and low-prevalence populations. We refer to this approach as "proactive prevention." This emphasis is based on the priority to put in place policies, programs, and infrastructure that can disrupt the epidemiological transition to develop NCDs among these groups, thereby averting future NCD crises. Proactive prevention strategies can be classified, and their implementation prioritized, based on a 2-dimensional assessment: impact and feasibility. Thus, potential interventions can be categorized into a 2-by-2 matrix: high impact/high feasibility, high impact/low feasibility, low impact/high feasibility, and low impact/low feasibility. We propose that high impact/high feasibility interventions are ready to be implemented (act), while high impact/low feasibility interventions require efforts to foster buy-in first. Low impact/high feasibility interventions need to be changed to improve their impact while low impact/low feasibility might be best re-designed in the context of limited resources. Using this framework, policy makers, public health experts, and other stakeholders can more effectively prioritize and leverage limited resources in an effort to slow or prevent the evolving global NCD crisis.

Indexed as

Cost of IllnessHealth PrioritiesHumansNoncommunicable DiseasesPolicy MakingRisk Factors

Identifiers

PMID33259517
PMCPMC7707577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.